Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Rises By 50.8%

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 46,600 shares, a growth of 50.8% from the October 15th total of 30,900 shares. Based on an average daily volume of 50,300 shares, the days-to-cover ratio is presently 0.9 days.

PURE Bioscience Price Performance

PURE remained flat at $0.16 during midday trading on Friday. 21,473 shares of the company’s stock traded hands, compared to its average volume of 28,810. The stock has a market cap of $17.62 million, a P/E ratio of -3.94 and a beta of 0.05. The stock’s 50-day moving average price is $0.09 and its 200 day moving average price is $0.08. PURE Bioscience has a fifty-two week low of $0.06 and a fifty-two week high of $0.17.

PURE Bioscience (OTCMKTS:PURE) last released its earnings results on Tuesday, October 29th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.47 million during the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.